Previous studies performed by our research team indicate that the metabolic imbalances due nuclear factor Erythroid 2-related Factor 2 (NRF2) and Kelch-Like ECH Associated Protein 1 (KEAP1) lead to poor outcomes in breast cancer patients [8,9]. This evidence concerns the gene KEAP1 and breast carcinoma.